Researchers succeed at removing some types of pancreatic cancer in animal models

by The Spanish National Cancer Research CentreAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResearchers from the Experimental Oncology

Updated on: June 24,2024

Researchers succeed at removing some types of pancreatic cancer in animal models

by The Spanish National Cancer Research CentreAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResearchers from the Experimental Oncology

Updated on:June 24,2024

A blood test for colon cancer performed well in a study, expanding options for screening

by Carla K. JohnsonThis image provided by Guardant Health in March 2024, shows packaging for their colon cancer blood test, Shield. According to a study published Wednesday, March 13, 2024, in the&nbs

Updated on: March 30,2024

A blood test for colon cancer performed well in a study, expanding options for screening

by Carla K. JohnsonThis image provided by Guardant Health in March 2024, shows packaging for their colon cancer blood test, Shield. According to a study published Wednesday, March 13, 2024, in the&nbs

Updated on:March 30,2024

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

by Cancer Research UKCredit: CC0 Public DomainA drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treat

Updated on: May 11,2024

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

by Cancer Research UKCredit: CC0 Public DomainA drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treat

Updated on:May 11,2024

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

by European Organisation for Research and Treatment of CancerProfessor Laura van 't Veer presented latest results from the I-SPY2 phase 2 clinical trial at the 14th European Breast Cancer Conferen

Updated on: March 30,2024

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

by European Organisation for Research and Treatment of CancerProfessor Laura van 't Veer presented latest results from the I-SPY2 phase 2 clinical trial at the 14th European Breast Cancer Conferen

Updated on:March 30,2024

Breast cancer patients can safely avoid extensive removal of lymph nodes if they respond well to systemic treatment

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainPatients with breast cancer that has started to spread to the lymph nodes in the armpit can safely avoid e

Updated on: March 30,2024

Breast cancer patients can safely avoid extensive removal of lymph nodes if they respond well to systemic treatment

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainPatients with breast cancer that has started to spread to the lymph nodes in the armpit can safely avoid e

Updated on:March 30,2024

Study shows many expensive cancer drugs have unclear patient benefit

byUniversity of GothenburgDiseases targeted in the included trials. Credit:Clinical Drug Investigation(2023). DOI: 10.1007/s40261-023-01285-4New cancer drugs are being launched rapid

Updated on: January 16,2024

Study shows many expensive cancer drugs have unclear patient benefit

byUniversity of GothenburgDiseases targeted in the included trials. Credit:Clinical Drug Investigation(2023). DOI: 10.1007/s40261-023-01285-4New cancer drugs are being launched rapid

Updated on:January 16,2024

Researchers report results in rare gynecologic cancers from DART immunotherapy trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of pat

Updated on: February 03,2024

Researchers report results in rare gynecologic cancers from DART immunotherapy trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of pat

Updated on:February 03,2024

A new strategy to enhance gene therapy for sickle cell disease

byMary Ann Liebert, IncCyclosporin H Improves the Transduction of CD34+ Cells with an Anti-Sickling Globin Vector, a Possible Therapeutic Approach for Sickle Cell Disease. Credit: Mary Ann Liebe

Updated on: November 22,2024

A new strategy to enhance gene therapy for sickle cell disease

byMary Ann Liebert, IncCyclosporin H Improves the Transduction of CD34+ Cells with an Anti-Sickling Globin Vector, a Possible Therapeutic Approach for Sickle Cell Disease. Credit: Mary Ann Liebe

Updated on:November 22,2024

Bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma: Poorer treatment outcomes

byVall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainTreatment with bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma associates wit

Updated on: December 28,2023

Bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma: Poorer treatment outcomes

byVall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainTreatment with bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma associates wit

Updated on:December 28,2023

US Preventive Services Task Force: Evidence still lacking for routine skin cancer screening

The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is currently insufficient for assessing the balance of benefits and harms of screening asymptomatic adolescents and adults

Updated on: January 02,2024

US Preventive Services Task Force: Evidence still lacking for routine skin cancer screening

The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is currently insufficient for assessing the balance of benefits and harms of screening asymptomatic adolescents and adults

Updated on:January 02,2024

Finding the Achilles heel of cancer

by Instituto Gulbenkian de CienciaHealthy cells (left image) display four centrioles, a normal number (in yellow). On the contrary, breast cancer cells (triple negative) have extra centrioles (he

Updated on: March 12,2024

Finding the Achilles heel of cancer

by Instituto Gulbenkian de CienciaHealthy cells (left image) display four centrioles, a normal number (in yellow). On the contrary, breast cancer cells (triple negative) have extra centrioles (he

Updated on:March 12,2024

Proportion of cancers associated with excess body weight varies considerably by state

by American Cancer SocietyCredit: CC0 Public DomainA new study looking at the share of cancers related to obesity finds an at least 1.5-fold difference between states with the highest and lowest

Updated on: March 06,2024

Proportion of cancers associated with excess body weight varies considerably by state

by American Cancer SocietyCredit: CC0 Public DomainA new study looking at the share of cancers related to obesity finds an at least 1.5-fold difference between states with the highest and lowest

Updated on:March 06,2024